2013 American Transplant Congress
Extent of Donor Smoking and Mid-Term Outcomes after Lung Transplantation – A Single Center Analysis
Objective In this study we retrospectively evaluated impact of donor history and extent of smoking on mid-term outcome after LTx.Methods Between 01.2007 and 09.2012, 237…2013 American Transplant Congress
High Frequency of Valganciclovir Under- and Overdosing for CMV Prophylaxis after Renal Transplantation
Department of Nephrology, Charite-Universitätsmedizin Berlin CCM, Berlin, Germany
The correct valganciclovir (vgc) dose for CMV-prophylaxis depends on renal function as assessed by the Cockroft Gault formula (CG-eGFR) for patients (pts) after transplantation (Tx).We…2013 American Transplant Congress
Strategy for Eliminating Passenger Leukocytes in Human Renal Allografts, A
Breonics, Inc., Albany; University Medical Center, Utrecht, Netherlands
Transplantation is unique immunologically due to both donor and recipient antigen presenting cells being present at reperfusion. Dendritic cells (DC) are a potent type of…2013 American Transplant Congress
Donor HSCs from the Bone Component of Vascularized Composite Allografts Migrate to Recipient Thymus and Differentiate to Mature T Cells
Introduction:Vascularized composite allografts (VCA) feature an inexhaustible source of donor HSCs, which under proper immunomodulation might be able to migrate into the recipient’s thymus and…2013 American Transplant Congress
Serum Cystatin C in Renal Transplantation: Beyond GFR Estimation, a Prognosis Marker?
Nephrology, Dialysis, Transplantation, University Hospital, Saint-Etienne, France
In renal transplantation, death with a functioning graft remains one of the main causes of graft loss. In the general population, renal function impairment is…2013 American Transplant Congress
Post-Transplant Complement Binding DSA: Higher Risk of Kidney Allograft Loss
Anti-HLA antibodies are a major obstacle to transplantation success. We hypothesized that the complement binding capacity of anti-HLA antibodies assessed in the recipient sera could…2013 American Transplant Congress
Kidney Re-Transplantation (reTx) in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD)
PTLD is a serious and potentially fatal complication of solid organ transplantation (Tx). It represents a spectrum of tumors ranging from benign lymphoid proliferation to…2013 American Transplant Congress
Regulation of microRNA in Ischemia Reperfusion Injury in Heart Transplantation, The
University of Western Ontario, London, Canada; Lawson Health Research institute, London, Canada
Background: MicroRNAs (miRNA) are single-stranded RNAs containing 18-24 nucleotides in length and have emerged as a prominent class of gene regulators. Due to their capacity…2013 American Transplant Congress
Prospective Comparative Study of a Strategy of Systematic Search and Treatment Versus No Treatment of Asymptomatic Bacteriuria (AB) in Kidney Transplant (KT) Recipients: Preliminary Results
BackgroundThe treatment of AB in KT recipients is controversial. To the very best of our knowledge this is the first prospective study about this issue.MethodsWe…2013 American Transplant Congress
Calcineurin Polymorphisms Associate with FK506 Dosage and Incidence of BK Viremia in Kidney Transplant Recipients
Background. Both over-immunosuppression and under-immunosuppression can endanger the health of a kidney transplant recipient (KTR). Genotyping KTRs to personalize the administration of immunosuppressive drugs, such…
- « Previous Page
- 1
- …
- 84
- 85
- 86
- 87
- 88
- …
- 178
- Next Page »